Chime Biologics Stock

Chime Biologics is a biopharmaceutical development and manufacturing company.

Sign up today and learn more about Chime Biologics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Chime Biologics Stock

Chime Biologics, is a world-class experienced Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide a comprehensive solution supporting our customers from analytical and process transfer to early-stage biopharmaceutical development through late-stage clinical and commercial drug substance and drug product manufacturing for Global Supply.

Funding History

March 2021$190M
February 2023$17.4M

Management

CEO

John (Xianfang) Zeng

Chairman and Board Director

Andrew Ng

Founder

John Zeng

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo